Identity
- Trade Name
- ArgoTrans™ FDA UDI
- Generic Name
- Invasive blood pressure transducer set FDA UDI
- Model / Reference
- 10884450332341 FDA UDI
Identifiers
- Catalog Number
- 041594505A/A FDA UDI
- Primary DI / UDI-DI
- 10884450332341 FDA UDI
- FDA Product Code
- DRS FDA UDI
- GMDN Term
- Invasive blood pressure transducer set FDA UDI
Classification
- Device Class
- Class II FDA UDI
- Regulation Number
- 870.2850 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
Yes
Single Use
Yes
Implantable
No
Contains Latex
No
Prescription Use
No
Over-the-Counter
No
Convenience Kit
Yes
Combination Product
No
HCT/P
No
Premarket Exempt
No
Lot / Batch Number
Yes
Serial Number
No
Expiration Date
Yes
Manufacturing Date
No
Category: Invasive blood pressure transducer set
Discover the ArgoTrans invasive blood pressure transducer set, a comprehensive solution for accurate and reliable blood pressure monitoring in medical settings. This single-use device provides precise pressure measurements with physical characteristics preserving waveform fidelity. Find out more about its features, compliance, and FAQs.
Similar devices
Also classified as Invasive blood pressure transducer set.
- ICU Medical — ICU MEDICAL, INC. · Class II
- Antmed — ShenZhen Antmed Co., Ltd · Class II
- Antmed — ShenZhen Antmed Co., Ltd · Class II
- Transpac™ — ICU MEDICAL, INC. · Class II
- Transpac™ — ICU MEDICAL, INC. · Class II
- ICU Medical — ICU MEDICAL, INC. · Class II
- ICU Medical — ICU MEDICAL, INC. · Class II
- Antmed — ShenZhen Antmed Co., Ltd · Class II
Authorization Coverage (1 country)
Regulatory Authorizations
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class II | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Merit Medical Systems, Inc.
Sources (1)
- FDA UDI 78204a4e-bd48-4eeb-bb94-c7f60aa11610 33 fields · synced Oct 6, 2026